Go Pro

Verrica Pharmaceuticals (VRCA) Institutional Ownership

Verrica Pharmaceuticals logo
$5.59 0.00 (0.00%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$5.40 -0.19 (-3.40%)
As of 07:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Verrica Pharmaceuticals (NASDAQ:VRCA)

Current
Institutional Ownership
Percentage
42.45%
Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$23.65M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$80.62M
Get VRCA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verrica Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VRCA Institutional Buying and Selling by Quarter

Verrica Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC32,360$171K0.0%+22.6%0.188%
2/18/2026XTX Topco Ltd14,662$122K0.0%N/A0.092%
2/18/2026Quadrature Capital Ltd11,954$99K0.0%N/A0.075%
2/18/2026Millennium Management LLC23,123$192K0.0%-67.9%0.145%
2/18/2026Man Group plc11,287$94K0.0%N/A0.071%
2/18/2026Armistice Capital LLC1,118,925$9.30M0.1%+75.1%6.998%
2/16/2026Squarepoint Ops LLC33,270$276K0.0%N/A0.208%
2/16/2026OMERS ADMINISTRATION Corp22,600$188K0.0%N/A0.141%
2/13/2026Marshall Wace LLP85,173$708K0.0%N/A0.533%
2/13/2026Walleye Capital LLC15,240$127K0.0%N/A0.095%
2/13/2026Affinity Asset Advisors LLC707,338$5.88M0.3%N/A4.424%
2/13/2026Kalehua Capital Management LLC235,779$1.96M1.8%N/A1.475%
2/13/2026Velan Capital Investment Management LP471,559$3.92M2.3%N/A2.949%
2/13/2026State Street Corp23,481$195K0.0%+14.1%0.147%
2/12/2026Beck Mack & Oliver LLC12,000$100K0.0%N/A0.075%
2/12/2026Jane Street Group LLC101,722$845K0.0%N/A0.636%
2/12/2026HRT Financial LP17,356$144K0.0%N/A0.109%
2/12/2026Renaissance Technologies LLC26,400$219K0.0%-9.6%0.165%
2/10/2026Goldman Sachs Group Inc.18,621$155K0.0%N/A0.116%
1/22/2026Legacy Trust17,234$143K0.0%N/A0.108%
1/20/2026Sovran Advisors LLC32,658$249K0.0%-55.8%0.204%
11/17/2025Armistice Capital LLC639,193$2.76M0.0%-92.8%6.764%
11/17/2025Millennium Management LLC71,990$310K0.0%-92.1%0.762%
11/17/2025Boothbay Fund Management LLC280,734$1.21M0.0%N/A2.971%
11/14/2025Caligan Partners LP923,910$3.98M0.5%-90.0%9.777%
11/14/2025Bridgeway Capital Management LLC12,000$52K0.0%N/A0.127%
10/31/2025Sovran Advisors LLC73,805$318K0.0%-90.2%0.781%
8/14/2025Armistice Capital LLC8,881,344$4.71M0.1%+3.7%96.015%
8/14/2025Qube Research & Technologies Ltd52,955$28K0.0%N/A0.572%
8/13/2025Marshall Wace LLP123,953$66K0.0%N/A1.340%
8/8/2025Geode Capital Management LLC646,156$343K0.0%-36.6%6.985%
8/1/2025 Y Intercept Hong Kong Ltd186,955$99K0.0%N/A2.021%
7/10/2025Sovran Advisors LLC750,391$398K0.0%+91.3%0.811%
6/27/2025Goldman Sachs Group Inc.139,055$61K0.0%+23.3%0.150%
5/16/2025Goldman Sachs Group Inc.139,055$61K0.0%+23.3%0.150%
5/16/2025AQR Capital Management LLC58,711$26K0.0%+306.7%0.063%
5/15/2025Armistice Capital LLC8,567,400$3.79M0.1%-4.0%9.266%
5/13/2025Kovitz Investment Group Partners LLC101,125$45K0.0%N/A0.109%
5/12/2025Invesco Ltd.74,388$33K0.0%+64.8%0.080%
5/9/2025Charles Schwab Investment Management Inc.99,505$44K0.0%+127.9%0.108%
Trump’s $250 Bill – See Immediately (Ad)

Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in modern history - larger than Paul Tudor Jones' Black Monday bet and Michael Burry's $700 million Big Short. While most investors chase AI stocks, insiders including Ray Dalio and Tudor Jones have quietly repositioned. The last comparable shock sent certain stocks up 2,464%, 2,778%, and even 13,000% - turning a $10,000 stake into over $1.3 million. Dr. Eifrig has identified one stock at the center of this story and released a free broadcast to help investors act before the window closes.tc pixel

Watch the free broadcast now and learn where to position your money
2/17/2025Bank of America Corp DE143,818$101K0.0%+347.5%0.315%
2/14/2025Caligan Partners LP7,429,687$5.20M1.4%N/A16.293%
2/14/2025Boothbay Fund Management LLC2,587,046$1.81M0.0%N/A5.673%
2/14/2025Heights Capital Management Inc.351,142$246K0.1%N/A0.770%
2/13/2025XTX Topco Ltd48,084$34K0.0%-79.2%0.105%
2/13/2025Renaissance Technologies LLC233,300$163K0.0%+57.7%0.512%
2/13/2025Invesco Ltd.45,132$32K0.0%N/A0.099%
2/12/2025Geode Capital Management LLC477,269$334K0.0%+4.8%1.047%
1/30/2025Rhumbline Advisers266,093$186K0.0%+975.2%0.584%
1/29/2025Sovran Advisors LLC407,050$267K0.0%N/A0.893%
1/23/2025SteelPeak Wealth LLC76,000$53K0.0%-25.5%0.167%
11/25/2024Sanctuary Advisors LLC60,000$87K0.0%N/A0.132%
11/19/2024Barclays PLC31,341$45K0.0%+404.6%0.069%
11/15/2024Barclays PLC31,341$45K0.0%+404.6%0.069%
11/15/2024XTX Topco Ltd231,148$335K0.0%N/A0.507%
11/15/2024Jane Street Group LLC69,872$101K0.0%+106.5%0.153%
11/15/2024State Street Corp512,821$744K0.0%+13.5%1.125%
11/14/2024Verition Fund Management LLC61,640$89K0.0%N/A0.135%
11/13/2024Propel Bio Management LLC344,937$500K0.3%-18.8%0.756%
11/13/2024FMR LLC634,310$920K0.0%-42.8%1.391%
11/6/2024Simplify Asset Management Inc.200,000$290K0.0%-28.6%0.469%
10/25/2024SteelPeak Wealth LLC101,998$148K0.0%-17.0%0.240%
10/11/2024Creative Planning19,018$28K0.0%-36.4%0.045%
8/13/2024Simplify Asset Management Inc.280,000$2.04M0.1%N/A0.660%
8/9/2024Renaissance Technologies LLC45,525$332K0.0%N/A0.107%
8/6/2024Quest Partners LLC6,926$50K0.0%N/A0.016%
8/1/2024Rhumbline Advisers26,591$194K0.0%+20.4%0.063%
7/30/2024Key Financial Inc9,415$69K0.0%N/A0.022%
7/26/2024Bank of New York Mellon Corp58,680$428K0.0%+8.1%0.138%
7/18/2024Miracle Mile Advisors LLC84,000$612K0.0%-28.9%0.198%
7/17/2024SteelPeak Wealth LLC122,836$895K0.0%-10.9%0.290%
5/10/2024Vanguard Group Inc.1,268,710$7.51M0.0%+0.6%2.991%
5/1/2024BNP Paribas Financial Markets10,342$61K0.0%-74.1%0.024%
2/26/2024Perceptive Advisors LLC7,099,182$51.97M1.2%+40.9%16.879%
2/14/2024Avoro Capital Advisors LLC3,999,999$29.28M0.4%+35.4%9.510%
2/2/2024Truist Financial Corp10,545$77K0.0%-33.8%0.025%
1/31/2024Kornitzer Capital Management Inc. KS74,251$544K0.0%-25.2%0.177%
1/30/2024BML Capital Management LLC180,000$1.32M1.0%+20.0%0.428%
11/13/2023FMR LLC1,504,716$5.85M0.0%+29.4%3.578%
11/9/2023Kovitz Investment Group Partners LLC50,125$195K0.0%+44.3%0.119%
11/7/2023New York State Common Retirement Fund9,123$35K0.0%-44.4%0.022%
11/7/2023Jump Financial LLC18,200$71K0.0%N/A0.043%
10/31/2023Kornitzer Capital Management Inc. KS99,251$386K0.0%-23.2%0.236%
8/4/2023American International Group Inc.10,048$58K0.0%N/A0.024%
8/3/2023SPC Financial Inc.30,000$173K0.0%N/A0.072%
8/1/2023Truist Financial Corp15,928$92K0.0%+41.0%0.038%
7/24/2023Vontobel Holding Ltd.13,570$78K0.0%N/A0.032%
5/16/2023Avoro Capital Advisors LLC2,650,000$17.23M0.3%N/A6.316%
5/11/2023Kovitz Investment Group Partners LLC34,725$226K0.0%+15.3%0.083%
5/9/2023Manchester Capital Management LLC10,000$65K0.0%N/A0.024%
Confirm Your Name Before the Letter Goes Out (Ad)

Americans who believe in real retirement protection are adding their names to a statement going out to Washington and Wall Street. It's a message that people are fed up with inflation and the erosion of their savings. President Trump took a stand on protecting American wealth. Now you can add your voice while also learning how to move part of your IRA or 401(k) into physical gold and silver, tax and penalty free.tc pixel

Add your name and claim your free Gold IRA Guide today.
5/3/2023Jump Financial LLC29,909$194K0.0%N/A0.071%
4/20/2023Miracle Mile Advisors LLC118,221$768K0.0%-5.4%0.282%
4/19/2023Legacy Trust18,750$122K0.0%N/A0.045%
4/14/2023BML Capital Management LLC150,000$975K0.8%-86.5%0.358%
2/13/2023BML Capital Management LLC1,110,605$3.05M2.9%N/A2.703%
2/10/2023Fosun International Ltd129,013$355K0.0%-54.3%0.314%
2/8/2023Conning Inc.129,013$355K0.0%N/A0.314%
1/19/2023Kovitz Investment Group Partners LLC30,125$83K0.0%N/A0.073%
11/14/2022Point72 Asset Management L.P.485,802$1.42M0.0%-35.6%1.182%
11/14/2022MML Investors Services LLC89,950$263K0.0%+104.9%0.219%


VRCA Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Verrica Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.30M), Affinity Asset Advisors LLC ($5.88M), Caligan Partners LP ($3.98M), Velan Capital Investment Management LP ($3.92M), Kalehua Capital Management LLC ($1.96M), Boothbay Fund Management LLC ($1.21M), and FMR LLC ($920K).Learn more on Verrica Pharmaceuticals' institutional investors.

42.45% of Verrica Pharmaceuticals' stock is owned by institutional investors. Learn more on VRCA's institutional investor holdings.

Of the 39 institutional investors that purchased Verrica Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Caligan Partners LP ($7.43M), Boothbay Fund Management LLC ($2.87M), Armistice Capital LLC ($793.68K), Sovran Advisors LLC ($765.28K), Affinity Asset Advisors LLC ($707.34K), Velan Capital Investment Management LP ($471.56K), and Heights Capital Management Inc. ($351.14K).

Institutional investors have bought a total of 3,234,928 shares in the last 24 months. This purchase volume represents approximately $23.65M in transactions.

The following institutional investors have sold Verrica Pharmaceuticals stock in the last 24 months: Caligan Partners LP ($8.32M), Armistice Capital LLC ($8.24M), Millennium Management LLC ($883.95K), Sovran Advisors LLC ($717.73K), Geode Capital Management LLC ($372.33K), and Renaissance Technologies LLC ($2.79K).

Institutional investors have sold a total of 18,534,167 shares in the last 24 months. This volume of shares sold represents approximately $80.62M in transactions.



This page (NASDAQ:VRCA) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners